Chronic bronchitis and plasma markers of inflammation predict incidence of COPD

G. Engström, M. Ekberg-Aronsson, P. Nilsson, F. Lindgärde, C. G. Löfdahl (Malmö, Sweden)

Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD
Session: Longitudinal and cross sectional risk factors for COPD
Session type: Oral Presentation
Number: 4017
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Engström, M. Ekberg-Aronsson, P. Nilsson, F. Lindgärde, C. G. Löfdahl (Malmö, Sweden). Chronic bronchitis and plasma markers of inflammation predict incidence of COPD. Eur Respir J 2007; 30: Suppl. 51, 4017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014


Exacerbation aetiology and inflammation markers in chronic obstructive bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 252s
Year: 2002

Clinical value of C-reactive protein in severe acute exacerbations of COPD
Source: Annual Congress 2005 - COPD - acute exacerbations
Year: 2005


Chronic bronchitis: a risk factor for bronchial infection
Source: Eur Respir Monogr 2013; 60: 18-26
Year: 2013


Changes in bronchial inflammation during acute exacerbations of chronic bronchitis
Source: Eur Respir J 2001; 17: 1112-1119
Year: 2001



Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016

Inflammatory changes, recovery and recurrence at COPD exacerbation
Source: Eur Respir J 2007; 29: 527-534
Year: 2007



Biomarkers in the management of COPD
Source: Eur Respir Rev 2009; 18: 96-104
Year: 2009



Defining the contribution of emphysema and chronic bronchitis in COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 539s
Year: 2003

Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies
Source: Eur Respir J 2008; 31: 70-77
Year: 2008



The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

Recruitment of blood fibrocytes during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4 dependent pathway
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015


Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013

BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013


Acute exacerbations of chronic obstructive pulmonary disease, clinical characteristics and predictors of exacerbations rate
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006

Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010


Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015


The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD)
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013


Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021